Pharmaceuticals & Medical Products


Pharma M&A: Agile shouldn’t mean ad hoc

– Under pressure to be active acquirers, some pharmaceutical and medical-products companies may be neglecting best practices. Here’s where they can most improve.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights


Improving healthcare while curbing cost: Med-tech companies offer a solution

– Research tells us that the potential value of partnering with med-tech companies is great. Yet many hospital executives are still... not fully satisfied.

The road to digital success in pharma

– Pharmaceutical companies can play a central role in the digital revolution of healthcare. But capturing this opportunity requires... identifying the right initiatives.

Capturing returns in healthcare

– New research finds that the healthcare sector has been very good to private equity, especially payor and pharmaceutical services.... And specialist firms seem to have an edge over generalists.

Africa: A continent of opportunity for pharma and patients

– Africa may be the only pharmaceutical market where genuinely high growth is still achievable. Here’s what’s driving... that strength and how companies should react.

AMNOG revisited

– AMNOG is here to stay. Pharma companies will have to learn to live with an unpredictable market-access process. With planning... and learning from the experiences to date, success in Germany is possible.

Maintaining momentum in Brazil’s pharmaceutical market

– Despite macroeconomic deceleration, we expect Brazil's pharma market to grow 7–10 percent per year until 2020. Double-digit... growth is possible, but will require a granular approach.

How medical-device manufacturers can transform marketing and sales capabilities

– Device manufacturers experiencing declining growth or narrowing margins may need to reevaluate their commercial models.

Capturing the new ‘value’ segment in medical devices

– The growing demand for products that are “good enough” and competitively priced has pushed medical-product manufacturers... to develop strategies to attract and retain this new segment of customers.

Is your CMO’s role evolving fast enough?

– The role of the Chief Medical Officer at pharmaceutical companies is evolving to improve patient care and outcomes.

Rapid growth in biopharma: Challenges and opportunities

– Biopharmaceuticals could become the core of the pharmaceutical industry, but not without significant transformation in the laboratory... and in strategy, technology, and operations.

A digital prescription for pharma companies

– Pharmaceutical and medical-device companies have been slow to adopt digitization. Here are five reasons they should get moving.

Connect with our Pharmaceuticals & Medical Products Practice